Method of self-administering a dopamine 2 receptor agonist

Details Method of self-administering a dopamine 2 receptor agonist Method of self-administering a dopamine 2 receptor agonist

A - Human Necessities

61

M

128/63

A61M 37/00 (2006.01)

Patent

CA 2037353

METHOD OF SELF-ADMINISTERING A DOPAMINE 2 RECEPTOR AGONIST Abstract of The Disclosure A method of self-administering a dopamine 2 receptor agonist in the treatment of substance abuse. The method comprises the steps of administering predetermined doses of a dopamine 2 receptor agonist over predetermined time intervals until the patient's craving ceases; then determining the cumulative dosage amount administered in the previous step; administering the cumulative dosage when the patient's craving recurs; and, finally, reducing the cumulative dosage amount as the patient's craving diminishes. Preferably, the dopamine 2 receptor agonist is bromocriptine, which is administered in combination with food after avoiding consumption of nicotine, cocaine, alcohol, amphetamines, and other stimulants for at least ten hours. Ideally, the doses are ingested orally by the patient to facilitate self-administration and control over dosage amount. Stimulating the dopamine 2 receptor with bromocriptine in self-administered doses avoids negative side effects and eliminates the patient's addiction to the treatment method. - 15 -

Affiliated with

Also associated with

Rating

Method of self-administering a dopamine 2 receptor agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of self-administering a dopamine 2 receptor agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of self-administering a dopamine 2 receptor agonist will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1620030